Stock MESO MESOBLAST LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Mesoblast Limited Nasdaq

Equities

MESO

US5907174016

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
6.24 USD +1.46% Intraday chart for Mesoblast Limited +19.77% +183.64%
01/04 ADRs End Higher; Connect Biopharma Climbs 26% DJ
28/03 ADRs End Lower; NuCana Slides 15% DJ

Chart calendar Mesoblast Limited

d90e544.5rJKtqipdtaeaF9sbYKaJmKdo9zzdEpMZxVpq9bi7nM.j4MP8c_LTpTdHytfI-PVUDvc6-SsGwYWHn4-mOSutCSJ8CD10tga5fUeKA~c2c663f5e110145bb70b7bb547be4917

Upcoming events on Mesoblast Limited

29/05/2024 Q3 2024 Earnings Release (Projected)
28/08/2024 Q4 2024 Earnings Release (Projected)
20/11/2024 Q1 2025 Earnings Release (Projected)
20/02/2025 Q2 2025 Earnings Release (Projected)

Past events on Mesoblast Limited

29/02/2024 03:30 am Q2 2024 Earnings Call
29/02/2024 03:24 am Q2 2024 Earnings Release
31/01/2024 07:09 am December 2023 Sales and Revenue Release - Activities Report
05/12/2023 Rights Issue: 1 new share @ 0.3 AUD for 4 existing shares
28/11/2023 06:30 am Annual General Meeting
31/10/2023 03:32 am September 2023 Sales and Revenue Release - Activities Report
31/08/2023 04:00 am Q4 2023 Earnings Call
31/08/2023 03:50 am Q4 2023 Earnings Release
04/08/2023 Remestemcel-L FDA Update Call
31/07/2023 05:19 am June 2023 Sales and Revenue Release - Activities Report
21/06/2023 02:00 am Maxim Group Virtual Healthcare Conference
26/05/2023 04:02 am Q3 2023 Earnings Release
26/05/2023 04:00 am Q3 2023 Earnings Call
28/04/2023 05:54 am March 2023 Sales and Revenue Release - Activities Report
28/02/2023 03:00 am Q2 2023 Earnings Call
28/02/2023 02:40 am Q2 2023 Earnings Release
15/02/2023 American Society for Transplantation and Cellular Therapy Tandem Meeting
31/01/2023 12:52 pm December 2022 Sales and Revenue Release - Activities Report
23/11/2022 Annual General Meeting
23/11/2022 03:19 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million AUD		Released
Forecast
Spread 		24,8
23,4
6.13%		44,6
61,7
-27.8%		10,2
42,6
-76%		14,8
27,5
-45.97%		11,6
12,8
-9.48%
11,5

EBITDA
Million AUD		Released
Forecast
Spread 		-116
-144
19.78%		-97,4
-86,7
-12.33%		-116
-101
-15.08%		-102
-95,6
-6.24%		-89,1
-105
15.4%
-61,5

EBIT
Million AUD		Released
Forecast
Spread 		-119
-135
11.76%		-102
-90,3
-13.51%		-122
-102
-19.05%		-108
-96,8
-11.46%		-95,4
-112
14.7%
-76,5

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-147
-151
2.55%		-121
-107
-12.64%		-137
-102
-34.05%		-133
-117
-13.77%		-126
-133
4.77%
-103

Net income
Million AUD		Released
Forecast
Spread 		-133
-136
1.72%		-108
-97,1
-11.06%		-135
-106
-27.9%		-133
-119
-11.59%		-126
-133
5.27%
-103

EPS
AUD		Released
Forecast
Spread 		-0,54
-0,56
3.19%		-0,41
-0,36
-12.28%		-0,45
-0,25
-76.32%		-0,41
-0,19
-113.8%		-0,34
-0,17
-102.99%
-0,11

Announcement Date29/08/1926/08/2030/08/2130/08/2230/08/23-

Quarterly results

Fiscal PeriodJune 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 S2
Net sales
Million AUD		Released
Forecast
Spread 		29,3
31,7
-7.8%		18,0
17,7
1.68%		4,60
4,44
3.52%		5,36
5,51
-2.78%		3,34
3,94
-15.23%


2,81
14,1
-80.08%		3,23
14,4
-77.52%		6,16
7,29
-15.57%		2,27
5,10
-55.52%		3,17
3,04
4.39%		5,41
5,80
-6.78%		2,98
3,20
-6.77%		3,29
3,62
-8.94%		5,95
8,90
-33.12%
0,00


5,76

5,22
5,67
-7.99%
0,00


6,61


4,00


0,00


5,84


5,61


0,00


6,23

EBITDA
Million AUD		Released
Forecast
Spread 		-39,9
-36,1
-10.67%		-61,1
-68,3
10.51%		-58,2
-77,3
24.71%		-54,4
-45,1
-20.75%


-52,6
-51,1
-2.97%





-47,1
-42,3
-11.43%





-42,6
-51,1
16.69%





-45,0
-53,6
15.91%





-30,6
-41,1
25.51%























EBIT
Million AUD		Released
Forecast
Spread 		-42,5
-38,7
-9.76%		-63,9
-70,7
9.71%		-60,8
-79,5
23.46%		-57,5
-48,2
-19.51%		-29,0
-32,9
12.08%		-55,7
-54,2
-2.64%		-24,3
-19,5
-24.57%		-24,9
-13,1
-90.89%		-50,3
-47,9
-4.85%		-18,8
-30,2
37.76%		-27,3
-26,8
-2.07%		-45,8
-56,6
19.02%		-21,0
-32,4
35.11%		-27,0
-29,5
8.7%		-49,4
-63,9
22.78%
-26,7


-27,8

-34,4
-44,2
22.21%






-42,3








-44,1





-45,9

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread


-73,4
-81,1
9.55%		-66,0
-79,3
16.77%		-66,8
-31,5
-112.18%		-36,5
-35,9
-1.54%


-29,8
-21,4
-39.46%		-31,2
-15,0
-108.54%		-62,3
-54,9
-13.33%		-25,6
-36,7
30.44%		-36,5
-30,4
-19.95%		-61,7
-65,6
5.95%		-28,7
-39,5
27.47%		-33,8
-35,3
4.32%		-63,9
-81,1
21.22%
-26,7


-27,8

-50,3
-55,8
9.92%






-57,7








-59,7





-64,2

Net income
Million AUD		Released
Forecast
Spread 		-45,9
-45,7
-0.28%		-66,2
-68,7
3.7%		-65,1
-78,5
17.09%		-66,6
-48,2
-38.08%		-36,4
-35,9
-1.22%


-29,7
-20,8
-42.59%		-31,2
-18,7
-66.34%		-62,1
-49,1
-26.49%		-25,5
-36,7
30.66%		-36,4
-30,4
-19.67%		-61,5
-65,3
5.72%		-28,6
-39,5
27.61%		-33,8
-35,3
4.49%		-62,4
-77,2
19.17%
-26,7


-27,8

-50,1
-55,5
9.72%






-57,7








-59,7





-64,2

EPS
AUD		Released
Forecast
Spread








-0,21
-0,07
-202.69%		-0,11
-0,14
18.71%








-0,10
-0,06
-66.72%


-0,10
-0,04
-124.41%		-0,17
-0,10
-77.66%		-0,08
-0,17
53.02%		-0,09
-0,07
-26.35%








-0,06
-0,06
6.79%






-0,06








-0,06





-0,06

Announcement Date26/02/2026/08/2026/02/2130/08/2124/02/2224/02/2201/06/2230/08/2230/08/2222/11/2227/02/2327/02/2325/05/2330/08/2330/08/23--28/02/24--------

Upcoming sector events for Mesoblast Limited

29/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
29/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
30/04/2024 01:35 am QIAGEN N.V.: Q1 2024 Earnings Release
30/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
01/05/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Mesoblast Limited

27/04/2024 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
27/04/2024 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 10:30 am BB BIOTECH AG: Q1 2024 Earnings Release
26/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
26/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 04:30 pm MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 11:30 am PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MSB Stock
  4. MESO Stock
  5. Calendar Mesoblast Limited